Ashkon Software



AMGN Stock Report - Amgen Inc.

Amgen Inc. logo Amgen Inc. is a global biotechnology company that specializes in discovering, developing, manufacturing, and delivering human therapeutics. The company focuses on various therapeutic areas, such as inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Amgen's product portfolio includes Enbrel, which is used to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. Neulasta is another product that reduces the risk of infection due to a low white blood cell count in cancer patients. Prolia is used to treat postmenopausal women with osteoporosis, while Xgeva is used to prevent skeletal-related events. Otezla is used to treat adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh├žet's disease. The company also offers Aranesp to treat anemia and a lower-than-normal number of red blood cells, KYPROLIS to treat patients with relapsed or refractory multiple myeloma, and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization.

In addition to these products, Amgen also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA.

Amgen serves healthcare providers, such as physicians or their clinics, dialysis centers, hospitals, and pharmacies. The company distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. Amgen has collaboration agreements with several other companies, including Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc.

Amgen also has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases. Furthermore, Amgen has research and development collaborations with Neumora Therapeutics, Inc. and Plexium, Inc.

Amgen was incorporated in 1980 and is headquartered in Thousand Oaks, California.


Stock Sector: Drugs: Biotechnology


Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer